ATXS
Price
$6.47
Change
+$0.65 (+11.17%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
365.69M
57 days until earnings call
CCCC
Price
$2.06
Change
-$0.10 (-4.63%)
Updated
Mar 11, 04:59 PM (EDT)
Capitalization
145.88M
57 days until earnings call
Ad is loading...

ATXS vs CCCC

Header iconATXS vs CCCC Comparison
Open Charts ATXS vs CCCCBanner chart's image
Astria Therapeutics
Price$6.47
Change+$0.65 (+11.17%)
Volume$16.41K
Capitalization365.69M
C4 Therapeutics
Price$2.06
Change-$0.10 (-4.63%)
Volume$64.99K
Capitalization145.88M
ATXS vs CCCC Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. CCCC commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Hold and CCCC is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (ATXS: $5.82 vs. CCCC: $2.16)
Brand notoriety: ATXS and CCCC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 115% vs. CCCC: 38%
Market capitalization -- ATXS: $365.69M vs. CCCC: $145.88M
ATXS [@Biotechnology] is valued at $365.69M. CCCC’s [@Biotechnology] market capitalization is $145.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileCCCC’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • CCCC’s FA Score: 1 green, 4 red.
According to our system of comparison, CCCC is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 3 TA indicator(s) are bullish while CCCC’s TA Score has 3 bullish TA indicator(s).

  • ATXS’s TA Score: 3 bullish, 3 bearish.
  • CCCC’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, both ATXS and CCCC are a good buy in the short-term.

Price Growth

ATXS (@Biotechnology) experienced а -4.59% price change this week, while CCCC (@Biotechnology) price change was -10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.61%. For the same industry, the average monthly price growth was -8.15%, and the average quarterly price growth was -7.40%.

Reported Earning Dates

ATXS is expected to report earnings on May 08, 2025.

CCCC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+0.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($366M) has a higher market cap than CCCC($146M). ATXS YTD gains are higher at: -34.899 vs. CCCC (-40.000). ATXS (-100.97M) and CCCC (-103.45M) have comparable annual earnings (EBITDA) . ATXS has more cash in the bank: 344M vs. CCCC (256M). ATXS has less debt than CCCC: ATXS (5.64M) vs CCCC (67.1M). CCCC has higher revenues than ATXS: CCCC (33.7M) vs ATXS (0).
ATXSCCCCATXS / CCCC
Capitalization366M146M251%
EBITDA-100.97M-103.45M98%
Gain YTD-34.899-40.00087%
P/E RatioN/AN/A-
Revenue033.7M-
Total Cash344M256M134%
Total Debt5.64M67.1M8%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
93
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSCCCC
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 26 days ago
83%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 8 days ago
88%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X78532.000000-2069.039000
-2.57%
Bitcoin cryptocurrency
SPY560.58-15.34
-2.66%
SPDR® S&P 500® ETF Trust
AAPL227.48-11.59
-4.85%
Apple
GME22.42-1.58
-6.58%
GameStop Corp
TSLA222.15-40.52
-15.43%
Tesla

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-5.98%
CRNX - ATXS
47%
Loosely correlated
+1.41%
KYMR - ATXS
47%
Loosely correlated
+0.40%
IMNM - ATXS
46%
Loosely correlated
-5.25%
ABOS - ATXS
45%
Loosely correlated
-4.00%
CCCC - ATXS
44%
Loosely correlated
-8.47%
More

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-8.47%
KYMR - CCCC
59%
Loosely correlated
+0.40%
FATE - CCCC
49%
Loosely correlated
-8.24%
PRME - CCCC
47%
Loosely correlated
-13.33%
CRBU - CCCC
47%
Loosely correlated
-4.74%
ACAD - CCCC
46%
Loosely correlated
-2.11%
More